zinc coproporphyrin iii has been researched along with succimer in 1 studies
| Studies (zinc coproporphyrin iii) | Trials (zinc coproporphyrin iii) | Recent Studies (post-2010) (zinc coproporphyrin iii) | Studies (succimer) | Trials (succimer) | Recent Studies (post-2010) (succimer) |
|---|---|---|---|---|---|
| 119 | 6 | 43 | 1,665 | 57 | 269 |
| Protein | Taxonomy | zinc coproporphyrin iii (IC50) | succimer (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.72 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Mahasneh, QM; Tutunji, MF | 1 |
1 other study(ies) available for zinc coproporphyrin iii and succimer
| Article | Year |
|---|---|
Disappearance of heme metabolites following chelation therapy with meso 2,3-dimercaptosuccinic acid (DMSA).
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Coproporphyrins; Humans; Lead Poisoning; Male; Metallurgy; Occupational Diseases; Occupational Exposure; Porphobilinogen Synthase; Succimer | 1994 |